Your browser doesn't support javascript.
loading
Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer.
Cortes, J; Perez-Garcia, J; Levy, C; Gómez Pardo, P; Bourgeois, H; Spazzapan, S; Martínez-Jañez, N; Chao, T-C; Espié, M; Nabholtz, J M; Gonzàlez Farré, X; Beliakouski, V; Román García, J; Holgado, E; Campone, M.
Afiliação
  • Cortes J; Department of Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Department of Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: jacortes@vhio.net.
  • Perez-Garcia J; Baselga Institute of Oncology, Hospital Quiron, Barcelona, Spain; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.
  • Levy C; Centre François Baclesse, Caen, France.
  • Gómez Pardo P; Department of Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Bourgeois H; Clinique Victor Hugo, Le Mans, France.
  • Spazzapan S; Department of Medical Oncolo, Centro di Riferimento Oncologico (CRO) Aviano, Istituto di Ricerca e Cura a Carattere Scientifico, National Cancer Institute, Aviano, Italy.
  • Martínez-Jañez N; Department of Oncology, Ramón y Cajal University Hospital, Madrid, Spain.
  • Chao TC; Department of Oncology and Comprehensive Breast Health Center, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Espié M; Sénopôle Saint Louis Assistance Publique - Hôpitaux de Paris, Université Denis Diderot, Paris, France.
  • Nabholtz JM; Oncology Centre, King Saud University Medical City, Riyadh, Saudi Arabia.
  • Gonzàlez Farré X; Instituto Oncológico Dr Rosell - Hospital General de Catalunya, Sant Cugat del Vallès; Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain.
  • Beliakouski V; Gomel Regional Clinical Oncology Dispensary, Gomel, Belarus.
  • Román García J; Medical Oncology Uni, Instituto Oncológico Baselga, Hospital Ruber Internacional, Madrid, Spain.
  • Holgado E; Department of Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Medical Oncology Uni, Instituto Oncológico Baselga, Hospital Ruber Internacional, Madrid, Spain; Instituto Oncológico Baselga, Complejo Ruber Juan Bravo, Madrid, Spain.
  • Campone M; Medical Oncology Department, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.
Ann Oncol ; 29(4): 881-887, 2018 04 01.
Article em En | MEDLINE | ID: mdl-29481630
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vimblastina / Neoplasias da Mama / Antineoplásicos Alquilantes / Metástase Neoplásica / Antineoplásicos Fitogênicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vimblastina / Neoplasias da Mama / Antineoplásicos Alquilantes / Metástase Neoplásica / Antineoplásicos Fitogênicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article